Artificial intelligence in haemovigilance survey

1. Baseline demographic questions

Dear colleague,

The Haemovigilance Working Party of the International Society of Blood Transfusion (ISBT) in collaboration with the International Haemovigilance Network (IHN) and Serious Hazards of Transfusion (SHOT UK) are exploring the use of artificial intelligence (AI) in haemovigilance activities around the world. To understand use of AI for haemovigilance, we are conducting a survey which will be followed up by virtual interviews with some of the survey responders. We are interested in understanding if and how AI is being used globally for various aspects of haemovigilance, as well as the concerns, challenges, and opportunities AI presents. We will be inquiring about AI, which could include ChatGPT and other large language models, as well as any system/algorithms capable of performing tasks that typically require human intelligence such as understanding language, recognising patterns, and adapting to new information.

We are pleased to invite you to participate in this important survey and learn about your experience using AI in haemovigilance. This survey is made up of multiple-choice questions that should take less than 30 minutes of your time. Participation is completely voluntary. All responses will be anonymised regarding responder details in any reports related to the survey and your data will be handled per the ISBT privacy policy. You may terminate your participation at any time. Your decision to participate or not participate will not affect your relationship with ISBT, IHN, SHOT or any professional organisation. Only de-identified aggregated information will be shared at scientific meetings or in medical journals.

For those interested in further participation, we also plan to offer 1:1 virtual interviews following the survey to further explore this topic. If you are willing to be interviewed, please provide your contact details at the end of this survey. You are not obligated to provide contact details or participate in the interviews.

If you have any questions about this survey study, please do not hesitate to email ISBT via drgpatidar@gmail.com; IHN using this email: secretariat@ihn-org.com ; or SHOT via SHOT@nhsbt.nhs.uk. We will aim to get back to you within 5 working days.

Thank you for taking the time to read this information and for considering taking part in our survey. Your responses will help inform future educational and improvement activities to enhance transfusion safety.

ISBT Haemovigilance Working Party, IHN, and SHOT.

Question Title

* 1. From which of the following organisations did you receive the invitation to complete this survey? Select all that apply.

ISBT

IHN

SHOT

Other (please specify)

Question Title

* 2. Please select the WHO region in which you work.

Question Title

* 3. Please select the country in which you work.

Question Title

* 4. Name of your institution

Question Title

* 5. What is your job title?

Question Title

* 6. Job titles of others consulted

Question Title

* 7. Which of the following best described the type of institution in which you work? Select one.

National blood establishment /services/blood center (responsible for any of the following activities: recruiting donors; screening and selecting blood donors; blood collection; testing and processing blood units; transporting; receiving and storage and distribution of blood units for clinical transfusion at a national level)

National reference laboratory for blood transfusion

Regional blood services/blood center (responsible for recruiting donors; screening and selecting blood donors; blood collection; testing and processing blood units; transporting; receiving and storage of blood units; pre-transfusion testing, and issuing blood for clinical transfusion at a regional level)

Hospital-based blood services (a hospital unit performing the functions of blood establishment and transfusion services, including pre-transfusion compatibility testing and issuing blood for clinical transfusion, primarily for use within the hospital)

Hospital with no laboratory (a hospital providing care to patients)

Independent haemovigilance organisation

Regulatory body

Professional organisation

Other (please specify)

Question Title

* 8. Which patient populations does your institution serve? Select all that apply.
If your institution is not directly involved in patient care, choose not applicable.

Adult

Paediatric

Maternity and fetal

Not applicable

Question Title

* 9. What is your current role in haemovigilance? Select all that apply.

Blood bank staff/ Transfusion Scientist/ Laboratory staff

Clinician- Medical

Clinician-Nursing (including transfusion practitioner, haemovigilance officers)

Transfusion medicine specialist

Researcher

Data analyst

Quality/Risk Manager

Regulatory

Other (please specify)

Artificial intelligence in haemovigilance survey

1. Baseline demographic questions

Question Title

* 1. From which of the following organisations did you receive the invitation to complete this survey? Select all that apply.

Question Title

* 2. Please select the WHO region in which you work.

Question Title

* 3. Please select the country in which you work.

Question Title

* 4. Name of your institution

Question Title

* 5. What is your job title?

Question Title

* 6. Job titles of others consulted

Question Title

* 7. Which of the following best described the type of institution in which you work? Select one.

Question Title

* 8. Which patient populations does your institution serve? Select all that apply. If your institution is not directly involved in patient care, choose not applicable.

Question Title

* 9. What is your current role in haemovigilance? Select all that apply.

* 8. Which patient populations does your institution serve? Select all that apply.
If your institution is not directly involved in patient care, choose not applicable.